Invitae Corporation Invitae Corporation

Invitae Corporation

NVTA

Classement en actions #35791
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Prix de l'action
$0.016
Dernière synchronisation: 2024-03-11
Capitalisation boursière
$3.27M
Changement (1 jour)
-5.33%
Changement (1 an)
5,233.33%
Pays
US
Échange Invitae Corporation (NVTA)

Catégorie

Healthcare
EPS pour Invitae Corporation (NVTA)
EPS au September 2023 TTM : $-5.38
Selon les derniers rapports financiers et le cours de l'action de Invitae Corporation, l’EPS actuel de la société (TTM) est de $-5.38. À la fin de 2022, la société avait un EPS de $-13.18 une augmentation par rapport à celui de 2021, qui était de $-1.80.
Historique de l'EPS de Invitae Corporation de 2016 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-5.38 -100.00%
2023 0.00 -100.00%
2022 $-13.18 632.22%
2021 $-1.80 -59.73%
2020 $-4.47 68.05%
2019 $-2.66 37.11%
2018 $-1.94 -26.79%
2017 $-2.65 -12.25%
2016 $-3.02 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$18.62 -446.10%
US
$5.65 -205.02%
US
$-1.36 -74.72%
US
- -
CN
$5.09 -194.61%
US